The AAMC and the association-convened Ad Hoc Group for Medical Research joined nearly 800 partners in a May 15 letter urging congressional leaders to provide robust investments in nondefense discretionary (NDD) programs in fiscal year (FY) 2024. Examples of NDD programs include the National Institutes of Health, the Health Resources and Services Administration, the Centers for Disease Control and Prevention, and other federally funded health and science programs.
The signatories urged Congress to “reject cuts to NDD appropriations and instead set funding for fiscal year 2024 at a level that recognizes both rising costs and the need for investment in programs important to fostering economic growth and meeting human needs.”
The letter followed House passage of the Republican-supported Limit, Save, Grow Act of 2023 (H.R. 2811), which would cut FY 2024 funding to FY 2022 spending levels and restrict future spending growth to 1% per year for 10 years.